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Objective. To assess the performance of extended lower limb venous ultrasound (US) for the diagnosis of asymptomatic deep
vein thrombosis (DVT) and to estimate a 3-month DVT incidence on repeated US after total hip replacement.
Design. Diagnostic performance study and prospective cohort study.
Materials and methods. US was compared to phlebography in 70 consecutive patients and interobserver agreement was
assessed in the last 48 patients at day 8. US was repeated in these 48 patients at day 13 and day 90.
Results. Phlebography demonstrated a DVT in 18/70 (26%) patients, with five proximal and 13 distal and US in 23/70
(33%) patients, with eight proximal and 15 distal. Sensitivity and specificity of US with 95% CI were 94% (73–100) and
89% (76–96), respectively. Sensitivity in isolated distal vein thrombosis was 92% (67–99). The Kappa coefficient for
agreement between observers was 0.84 (0.66–1.00). Follow-up showed a DVT in 15/48 (31%) patients on day 8, in 20/48
patients (42%) on day 13. DVT recurred in two patients during follow-up.
Conclusions. The incidence of asymptomatic DVT is still significant despite prophylaxis but most DVTs remain distal and
occur in the first 2 weeks. Extended US could replace phlebography for systematic screening in clinical trials using surrogate
endpoints in view of its high accuracy and reliability.
Key Words: Ultrasonography; Phlebography; Asymptomatic; Deep vein thrombosis; Calf; Total hip replacement;
Surveillance.
Introduction
The prevalence of asymptomatic deep vein thrombosis
(DVT) following major orthopaedic surgery remains
high despite adequate prophylaxis. There are two
potential advantages in screening patients for asymp-
tomatic DVT: firstly, to help decide on treating those
suffering from DVT with anticoagulants and secondly,
to compare the efficacy of different prophylaxis regi-
mens.1 Although the clinical relevance of many of the
thrombi found by screening is questionable, phlebo-
graphy detected thrombosis is nevertheless con-
sidered a valid outcome measure. However,
phlebography, the reference standard, is invasive, no
longer widely accepted by patients or ethics commit-
tees, expensive and is associated with a risk related to
the administration of contrast media. It also has some
limitations due to a significant rate of inadequate
studies and to considerable intra- and interobserver
disagreement in interpretation of the results.2 – 6 For
these reasons, systematic phlebography is no longer
widely used as a screening method.
An alternative to phlebography is the use of venous
ultrasonography (US), a non-invasive method, which
has proved to be very accurate and is widely accepted
for the diagnosis of DVT in symptomatic patients.7 – 10
However, its role as a screening test in high-risk
asymptomatic patients is controversial. The moderate
sensitivity in most studies.11,12 is thought to be related
to the small size of the thrombus that is more often
confined to the distal (infra-popliteal) veins.11 Pub-
lished work addressing the accuracy of US examin-
ation in asymptomatic patients included considerable
variation in the technical approach between series, and
few studies attempted evaluation of the distal veins to
detect isolated calf vein thrombosis.2,13,14 There is as
yet no ideal screening method and an accurate,
inexpensive non-invasive test is required to assess
the entire venous network.
Eur J Vasc Endovasc Surg 27, 438–444 (2004)
doi: 10.1016/j.ejvs.2003.12.021, available online at http://www.sciencedirect.com on
*Corresponding author. Antoine Elias, MD, PhD, Department of
Vascular Medicine, Rangueil University Hospital Centre-1, Avenue
Jean Poulhe`s 31403, Toulouse cedex 04, France.
1078–5884/040438 + 07 $35.00/0 q 2003 Elsevier Ltd. All rights reserved.
Objective
The objective of this study was:
1. To assess the diagnostic accuracy of an extended US
test as compared to phlebography in high-risk
asymptomatic patients.
2. To study the reproducibility of performing and
interpreting an extended US.
3. Finally, to estimate by repeated US the incidence of
DVT during a 3-month follow-up, following 1
month of prophylaxis with a low molecular weight
heparin, whether or not patients had an isolated
calf DVT on the initial screening US.
Methods
Study design
To study diagnostic accuracy, we compared US to
phlebography prospectively in 74 consecutive asymp-
tomatic patients undergoing a total hip replacement.
Non-inclusion criteria consisted of patients with a
previous history of DVT or pulmonary embolism
based on clinical and preoperative ultrasound assess-
ment, a contraindication to phlebography or to antic-
oagulant treatment. The research protocol was
approved by the local ethics committee. Patients
giving informed written consent were included in
the study. Both US and phlebography were performed
by independent investigators on day 8 ^ 1, with an
interval of less than 24 h between the investigations.
Findings were interpreted blindly according to pre-
established criteria to confirm or exclude the diagnosis
of DVT. The sensitivity and the specificity of US and
95% confidence intervals (CI) were calculated using
the Wilson’s method15 on the basis of number of
patients or lower extremities studied. Phlebography
was taken as the reference standard for these
calculations.
The final 48 patients were studied in order to
investigate the interobserver agreement of the US test.
Two operators, unaware of each other’s results
performed and interpreted an US examination of the
lower limb veins at an interval of less than half an hour
during the day 8 studies. They used a standardised
protocol and the same criteria to exclude or to confirm
the presence of DVT. Results were recorded on a chart
according to the location and extent of the thrombus
but no video recording was made for later comparison.
Similarly, interobserver agreement was also assessed
for the phlebogram studies in the same patient sample.
Two independent observers examined the X-ray films
and recorded their findings according to a pre-defined
system. Agreement was analysed using Cohen’s
kappa statistic. A kappa coefficient ,0.2 represented
poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80
good and 0.81–1.00 very good agreement between two
observers.
The follow-up study included these 48 consecutive
patients, in a surveillance program lasting for a period
of 3 months and using the US at different time
intervals (days 0, 8 ^ 1, 13 ^ 1, and 90 ^ 5). A
radioisotope ventilation perfusion scan was per-
formed on day 8 ^ 1 as well as duplex ultrasonogra-
phy and phlebography. Patients were asked to return
to the centre in the case of any medical event. Only
patients with proximal DVT were treated with antic-
oagulants and initiation of treatment was based on the
results of either US examination or phlebography.
Patients who had no DVT or who had an isolated calf
DVT received prophylaxis with a low molecular
weight heparin for 30–40 days as there is no consensus
on the need for anticoagulation in asymptomatic
patients with isolated calf vein thrombosis. The antic-
oagulant prophylactic regimens used in this cohort
were as follows: Enoxaparin 40 mg injected subcu-
taneously (SC) once daily in 23 patients (48%),
Nadroparin 38 U/kg SC once daily on the first three
postoperative days then 57 U/kg SC once daily in 14
patients (29%), and Dalteparin 5000 U SC once daily in
11 patients (23%).
We considered only the results of US or phlebo-
graphy from the observer(s) who performed and
interpreted the test(s) in every patient for the entire
study (71 patients) when assessing US accuracy. The
results from the second observer(s) were not used
except for assessment of interobserver agreement (48
patients).
Diagnostic tests
Venous ultrasonography
An extended lower limb venous US examination
including the proximal and distal veins was per-
formed according to a standardised protocol. An
Ultramark 9 HDI (high definition imaging) US
machine from Philips ATL (Advanced Technology
Laboratories) was used. Appropriate probes were
selected according to the depth of the vessels
examined. We have previously validated this tech-
nique.7 Doppler US examination was undertaken in
the common femoral vein to assess the venous signal
as a measure of the patency of the iliac vein and B
mode US to image the vessels. The whole venous
network was scanned bilaterally: the inferior vena
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cava and the iliac veins with the patient supine or in
the lateral position when possible, the femoral veins
and the popliteal vein with the patient in a semi-
upright position, and finally the calf in the sitting
position with the patient’s feet on a chair. Calf veins
were studied using various views: antero-medial,
posterior and postero-lateral. Calf veins included the
posterior tibial and the peroneal veins up to their
confluence, the gastrocnemius (medial and lateral)
veins and the soleus (muscular) veins. The anterior
tibial veins were not investigated given that they are
rarely affected by DVT. The veins were investigated
along their entire length in transverse and longitudinal
views. Great and short saphenous veins at their
junctions with the deep venous system were also
studied. The diagnostic criteria used to confirm or
exclude DVT relied on the compression test and on the
absence or the presence of endoluminal material. The
US test was considered negative when the veins were
fully compressible with no thrombus visualised. The
test was positive when vein incompressibility was
combined with the direct image of an endoluminal
thrombus, and inadequate when incompressibility
was very limited (less than 1 cm) without visualisation
of a direct image of the thrombus.
Phlebography
Phlebography was performed by injecting 60–80 ml of
non-ionic low osmolality contrast agent (OmnipaqueR)
into a dorsal foot vein in both lower limbs. The patient
lay supine with tourniquets placed around the lower
part of the calf and the thigh, in order to direct the
contrast to the deep venous system. The diagnostic
criteria for DVT were the finding of a constant
intraluminal-filling defect. The location of thrombosis
was defined as proximal or distal as for US investi-
gation. Phlebography was considered negative when
at least four main venous segments within the calf, as
well as all the proximal veins up to the external iliac
veins, were opacified without any equivocal image.
Phlebography was otherwise interpreted as
inadequate.
Popliteal level
In order to distinguish proximal from distal vein
thrombosis, the level of the popliteal vein which varies
between series, was defined on US and phlebography
as the vein segment above the confluence of the
posterior tibial and the peroneal veins; this limit is
easily recognised on US and is very close to the point
where the anterior tibial vein reaches the popliteal
vein. All vein segments including the main veins and
the muscular veins below this confluence as well as the
gastrocnemius veins were defined as distal veins.
Data analysis
Sensitivity and specificity of US as compared to
phlebography were computed according to the results
from the observer who performed the tests in the
whole population sample.
For data analysis, the confidence interval analysis
software (CIA software version 2.0.0, University of
Southampton, UK) was used.15
Results
Diagnostic accuracy
For the diagnostic performance study, 74 patients were
eligible but four patients were not included because of
an inadequate phlebography in one patient and
because of the presence of a preoperative DVT
detected in three patients (one bilateral femoral iliac
DVT, two distal DVTs). Data analysis was therefore
undertaken in 70 patients (140 legs). There were 38
females (54%) and 32 males (46%) and mean age was
61 (SD 16) years. Results by patients and by legs are
shown in Table 1.
US detected all proximal DVTs (5/5) that were
shown on phlebography and all except one calf (distal)
DVT: 12/13 (92%) on the basis of analysis by patient,
and 18/19 (95%) on an analysis by limbs. The
sensitivity of US in isolated calf vein thrombosis was
estimated at 92% (67–99) and 95% (75–99), respect-
ively. The calf DVT missed on US was a very small
(1 cm) soleus vein thrombus.
Conversely, six patients (nine limbs) had DVTs
diagnosed by US that were not shown by phlebogra-
phy. In three cases, DVTs were located in the proximal
veins and were very small in length: once in the
superficial femoral vein (less than 2 cm) and twice in
the profunda femoral vein (more and less than 2 cm).
In six other legs, the thrombus was located in the soleal
veins segments and measured less than 2 cm in three
legs, between 2 and 5 cm in two, and more than 5 cm
in one.
If the phlebogram results were also analysed taking
the US examination as the reference standard, the
sensitivity and specificity of phlebography would
have been respectively: 74% (54–88) and 98% (89–
100) on the basis of analysis by patients, and 72% (55–
84) and 99% (95–100) on the basis of analysis by limbs.
Interobserver agreement
The interobserver agreement for the US investigation
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(Table 2) was very good either for an analysis by
patients (kappa ¼ 0.84 (0.66–1.00)) or for analysis by
limbs (kappa ¼ 0.81 (0.64–0.97)). The two investi-
gators did not agree for two proximal and three distal
vein interpretations. Between reader agreement for
phlebography was good for the patients analysis
(kappa ¼ 0.78 (0.55–1.00)) and for the limbs analysis
(kappa ¼ 0.73 (0.5–0.96)). There was disagreement in
interpretation of phlebography for one proximal vein
and four calf veins.
Surveillance
The US follow-up study (Table 3) showed on day 8 a
proximal DVT in seven patients with an asymptomatic
PE in one, a distal DVT in eight and no DVT in 33.
Therefore, 15/48 (31%) patients had a DVT detected by
US on day 8. On day 13, four additional calf DVT and
one additional proximal DVT were detected by
ultrasound in patients initially free from DVT. One
more proximal DVT developed in a patient presenting
initially a calf DVT. Thus five additional DVTs were
detected on day 13 as compared to day 8, accounting
for a total of 20/48 patients (42%) with DVT.
According to the results of phlebography and US, on
days 8 and 13, most DVTs were located on the
operated side; in eight patients, DVT was bilateral
and was either isolated in the distal veins in four
patients or isolated in the proximal veins in one
patient, or both in the proximal and in the distal veins
in three patients. On day 90, all except four patients
had their US performed but there was no clinical event
in these four patients. Two patients had a recurrent
DVT on US on the same side with one proximal and
the other one distal. During the 3 months follow-up
period from day 8, of patients with a distal DVT
receiving prophylaxis, one distal DVT became bilateral
then extended into the popliteal on day 13 (13%), three
remained distally located and four recanalised. In the
DVT free patients group, there were one proximal and
four distal DVTs on follow-up (15%), despite adequate
prophylaxis. In this subgroup, DVT was bilateral in
three patients.
Discussion
The diagnostic accuracy of US was compared to
phlebography using a rigorous methodology: a pro-
spective study, consecutive patients, pre-defined diag-
nostic criteria for the study and the reference methods,
investigation and blind interpretation by independent
operators. The results show a diagnostic accuracy for
US higher than that published in other series. The
limited number of patients results in large CIs but the
method seems to be very accurate for the detection of
asymptomatic DVT, whether proximal or distal. The
results are quite different from those found in the
meta-analysis of Wells.11 Wells found a sensitivity of
only 62% for the detection of asymptomatic proximal
DVT in the qualified level 1 studies. However, the
series in this meta-analysis were heterogeneous. The
study technique varied from one series to another
using B mode, duplex or colour Doppler. Some series
used 2-point investigation only, few included calf
Table 1. Diagnostic accuracy of venous ultrasound
Phlebography þ Phlebography 2
Patients ðn ¼ 70Þ
US þ 17 (Prox. 5, Dist. 12) 6 (Prox. 3, Dist. 3)
US 2 1 (Dist. 1) 46
Prevalence (0.95 CI): 0.26 (0.17–0.37)
Accuracy (0.95 CI): 0.90 (0.80–0.96)
Sensitivity (0.95 CI): 0.94 (0.73–1.00)
Specificity (0.95 CI): 0.89 (0.76–0.96)
PPV (0.95 CI): 0.74 (0.54–0.88)
NPV (0.95 CI): 0.98 (0.89–1.00)
Legs ðn ¼ 140Þ
US þ 23 (Prox. 5, Dist. 18) 9 (Prox. 3, Dist. 6)
US 2 1 (Dist. 1) 107
Prevalence (0.95 CI): 0.17 (0.12–0.24)
Accuracy (0.95 CI): 0.93 (0.87–0.96)
Sensitivity (0.95 CI): 0.96 (0.80–1.00)
Specificity (0.95 CI): 0.92 (0.86–0.96)
US, ultrasound; Prox., proximal; Dist., distal; PPV, positive pre-
dictive value; NPV, negative predictive value.
Table 2. Reproducibility of ultrasound and phlebography
Reproducibility of ultrasound
Observer 1 US þ Observer 1 US 2
Patients
Observer 2 US þ 11 0
Observer 2 US 2 3 34
Cohen’s kappa (0.95 CI): 0.84 (0.66–1.00)
Legs
Observer 2 US þ 13 0
Observer 2 US 2 5 78
Cohen’s kappa (0.95 CI): 0.81 (0.64–0.97)
Reproducibility of phlebography
Observer 1 P þ Observer 1 P 2
Patients
Observer 2 P þ 7 2
Observer 2 P 2 1 37
Cohen’s kappa (0.95 CI): 0.78 (0.55–1.00)
Legs
Observer 2 P þ 8 2
Observer 2 P 2 3 81
Cohen’s kappa (0.95 CI): 0.73 (0.5–0.96)
Interobserver agreement evaluated in the last 48 patients for
Ultrasound (US). Interobserver interpretation of x-ray films assessed
for the last 47 patients undergoing phlebography (P). In one patient,
phlebography was inadequate.
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examination, different diagnostic criteria were
applied. The largest number of patients is in the series
of Davidson16 investigated using colour Doppler. This
method was shown to be insensitive by Lensing’s
study.17 Colour Doppler is even more limiting distally
where low flow velocities need to be augmented by
distal muscular compression. Regardless of the exam-
ination method, the sensitivity of US for detecting
isolated calf vein thrombosis is low to moderate.18 – 22
In the systematic review of Kearon10 which included
series up to 1997, the sensitivity of US for detecting
proximal and distal vein thrombosis was 62% (53–71)
and 53% (32–74), respectively. In different series21,
23 – 27 in orthopaedic surgery not included in this
systematic review, extended lower limb venous US
shows a sensitivity varying from 74 to 86%. Recent
results in the literature2,13,14,28 are consistent with
those obtained in our study with a distinctly higher
sensitivity for US compared to phlebography for both
proximal and distal DVT.2,13,14
We consider that reliable US examination for DVT
depends on: high quality equipment and adequate US
probes, systematic examination of all proximal and
distal veins in transverse and longitudinal views.
Diagnostic criteria should be based exclusively on
combination of both vein incompressibility and direct
images of thrombus and not on flow characteristics.
Contrarily to phlebography, US imaging provides
views of the extra-vascular structures and the muscle
veins, and shows directly the occlusive thrombus,
ensuring that veins are correctly identified and
completely assessed and thrombosis more specifically
identified. The failure to fill vein segments on
phlebography is not specifically associated with DVT
and can be related to a compression phenomenon such
as a haematoma or to technical problems of opacifica-
tion. Thus, DVTs are more easily visualised with US.
We acknowledge that very small thrombi may only be
shown on phlebography; however, this situation is
exceptional in our series. In agreement with other
series,7,13 we have found that the specificity of US, and
consequently its positive predictive value is related to
the lack of sensitivity of phlebography. In this series,
three proximal and three distal DVTs were shown on
US but not on phlebography. Considerable precau-
tions were taken in order to avoid false positive results
with US: diagnostic criteria for DVT included the
requirement to obtain an image of the thrombus as
well as to demonstrate incompressibility of the vein
with the patient being relaxed. In order to prevent
extravascular structures being mistaken for the image
of a thrombus, complete scanning of the vein was
performed until the upper or the lower limit of the
thrombus was visualised.
In common with other authors14,29 we found that
extended US is reliable when experienced operators
examined the same patients independently. The
diagnosis was based on the operators’ interpretation
since we did not use video recordings for subsequent
analysis. In comparison we used independent
interpretation of X-rays films to assess the outcome
of phlebography.
This non-invasive method is also useful for surveil-
lance in high risk patients as it can be performed and
repeated in the pre- and postoperative period. In our
study, preoperative screening enabled detection of an
asymptomatic DVT in three patients and in one of
them it was proximal and bilateral.
In general, the postoperative incidence of phlebo-
graphy detected DVT under adequate prophylaxis is
about 15–20% after total hip replacement (THR). A
higher incidence has been reported in large series
where either phlebography30 or US examination31 was
used and these are similar to the DVT rates we found
in the data presented above. Repeated US showed that
the highest rate of detected DVT was found in the first
2 weeks. The outcome is favourable as recanalisation
usually occurs and a thrombosis seldom remains or
recurs. A proximal DVT isolated or extended from the
distal part of the leg, occurs rarely in patients under
prophylaxis. The limited number of our surveillance
study patients in the two groups (calf DVT group and
DVT free group on initial screening) is not of help in
deciding on the need for an anticoagulant therapy. Our
Table 3. Incidence of deep vein thrombosis (DVT) on follow-up
Day 8 ^ 1
33 (68%) with no DVT
8 (17%) with distal DVT
7 (15%) with proximal DVT (1 asymptomatic PE)
Day 13 ^ 1: DVT progression
In DVT free patients group
1 patient had a proximal DVT
4 patients had a distal DVT
In distal DVT patients group
1 patient had a proximal DVT
Three month follow-up
2 DVT recurrences
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study was not empowered to address this question. In
two series, a systematic US screening for asympto-
matic DVT, in patients under adequate prophylaxis,
addresses the question of its utility32,33 and cost.34
Indeed, the clinical significance of asymptomatic DVT
remains controversial because of the differences in the
rate of phlebography detected DVT (15–20%) and the
thromboembolic events (3%).35 – 37 In a recent series the
value of treating asymptomatic patients with proximal
DVT after total hip arthroplasty has been challenged.38
In clinical practice, screening patients systemati-
cally for asymptomatic DVT seems not to be rec-
ommended. However, US examination could be
undertaken for patients at very high risk of venous
thromboembolism. In clinical trials using surrogate
endpoints, systematic US could be performed pre- and
postoperatively. In patients in whom no DVT is
detected, clinical and US surveillance could be used.
For complete documentation of a DVT phlebography
might have to be employed should video recording be
unavailable.
References
1 Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW,
Anderson Jr FA et al. Prevention of venous thromboembolism.
Chest 2001; 119(1 Suppl):132S–175S.
2 Atri M, Herba MJ, Reinhold C, Leclerc J, Ye S, Illescas FF
et al. Accuracy of sonography in the evaluation of calf deep vein
thrombosis in both postoperative surveillance and symptomatic
patients. AJR Am J Roentgenol 1996; 166(6):1361–1367.
3 Wille-Jorgensen P, Borris LC, Lassen MR, Jorgensen LN,
Hauch O, Nehen AM et al. Potential influence of observer
variation in thromboprophylactic trials. Haemostasis 1992; 22(4):
211–215.
4 Couson F, Bounameaux C, Didier D, Geiser D, Meyerovitz MF,
Schmitt HE et al. Influence of variability of interpretation of
contrast phlebography for screening of postoperative deep
venous thrombosis on the results of a thromboprophylactic
study. Thromb Haemost 1993; 70(4):573–575.
5 Lensing AW, Buller HR, Prandoni P, Batchelor D, Mole-
naar AH, Cogo A et al. Contrast phlebography, the gold
standard for the diagnosis of deep-vein thrombosis: improve-
ment in observer agreement. Thromb Haemost 1992; 67(1):8–12.
6 Kalodiki E, Nicolaides AN, Al-Kutoubi A, Cunningham DA,
Mandalia S. How gold is the standard? Interobservers’
variation on phlebograms. Int Angiol 1998; 17(2):83–88.
7 Elias A, Le Corff G, Bouvier JL, Benichou M, Serradimigni A.
Value of real time B mode ultrasound imaging in the diagnosis of
deep vein thrombosis of the lower limbs. Int Angiol 1987; 6(2):
175–182.
8 Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M,
Tomasella G et al. Detection of deep-vein thrombosis by real-
time B-mode ultrasonography. N Engl J Med 1989; 320(6):
342–345.
9 Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasono-
graphy in the diagnosis of suspected deep venous thrombosis
and pulmonary embolism. Ann Intern Med 1998; 129(12):
1044–1049.
10 Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive
diagnosis of deep venous thrombosis. McMaster Diagnostic
Imaging Practice Guidelines Initiative. Ann Intern Med 1998;
128(8):663–677.
11 Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J.
Accuracy of ultrasound for the diagnosis of deep venous
thrombosis in asymptomatic patients after orthopedic surgery.
A meta-analysis. Ann Intern Med 1995; 122(1):47–53.
12 Kearon C. Noninvasive diagnosis of deep vein thrombosis in
postoperative patients. Semin Thromb Hemost 2001; 27(1):3–8.
13 Barrellier MT, Jouen E, Creveuil C. Discrepancies between
the results of phlebography and Doppler ultrasonography in the
diagnosis of asymptotic venous thrombosis after total hip
prosthesis. False negatives of phlebography or false positives of
Doppler ultrasonography. J Mal Vasc 1998; 23(3):183–190.
14 Bressollette L, Nonent M, Oger E, Garcia JF, Larroche P,
Guias B et al. Diagnostic accuracy of compression ultrasono-
graphy for the detection of asymptomatic deep venous throm-
bosis in medical patients—the TADEUS project. Thromb Haemost
2001; 86(2):529–533.
15 Altman DG, Gardner MJ, Bryant TN. Statistics with confi-
dence: confidence intervals and statistical guidelines, 2nd ed.
London: BMJ Books, 2000.
16 Davidson HC, Mazzu D, Gage BF, Jeffrey RB. Screening for
deep venous thrombosis in asymptomatic postoperative ortho-
pedic patients using color Doppler sonography: analysis of
prevalence and risk factors. AJR Am J Roentgenol 1996; 166(3):
659–662.
17 Lensing AW, Doris CI, McGrath FP, Cogo A, Sabine MJ,
Ginsberg J et al. A comparison of compression ultrasound with
color Doppler ultrasound for the diagnosis of symptomless
postoperative deep vein thrombosis. Arch Intern Med 1997; 157(7):
765–768.
18 Borris LC, Christiansen HM, Lassen MR, Olsen AD, Schott
P. Comparison of real-time B-mode ultrasonography and
bilateral ascending phlebography for detection of postoperative
deep vein thrombosis following elective hip surgery. The Venous
Thrombosis Group. Thromb Haemost 1989; 61(3):363–365.
19 Borris LC, Christiansen HM, Lassen MR, Olsen AD, Schott
P. Real-time B-mode ultrasonography in the diagnosis of post-
operative deep vein thrombosis in non-symptomatic high-risk
patients. The Venous Thrombosis Group. Eur J Vasc Surg 1990;
4(5):473–475.
20 Mattos MA, Londrey GL, Leutz DW, Hodgson KJ, Ramsey DE,
Barkmeier LD et al. Color-flow duplex scanning for the
surveillance and diagnosis of acute deep venous thrombosis.
J Vasc Surg 1992; 15(2):366–375. discussion 375–6.
21 Rose SC, Zwiebel WJ, Murdock LE, Hofmann AA, Priest DL,
Knighton RA et al. Insensitivity of color Doppler flow imaging
for detection of acute calf deep venous thrombosis in asympto-
matic postoperative patients. J Vasc Interv Radiol 1993; 4(1):
111–117.
22 Magnusson MB, Nelzen O, Risberg B, Sivertsson R. A colour
Doppler ultrasound study of venous reflux in patients with
chronic leg ulcers. Eur J Vasc Endovasc Surg 2001; 21(4):353–360.
23 Mussurakis S, Papaioannou S, Voros D, Vrakatselis T.
Compression ultrasonography as a reliable imaging monitor in
deep venous thrombosis. Surg Gynecol Obstet 1990; 171(3):
233–239.
24 Tremaine MD, Choroszy CJ, Gordon GH, Menking SA.
Diagnosis of deep venous thrombosis by compression ultra-
sound in knee arthroplasty patients. J Arthroplasty 1992; 7(2):
187–192.
25 Elliott CG, Suchyta M, Rose SC, Talbot S, Ford C, Raskob G
et al. Duplex ultrasonography for the detection of deep vein
thrombi after total hip or knee arthroplasty. Angiology 1993; 44(1):
26–33.
26 Vanninen R, Manninen H, Soimakallio S, Katila T, Suoma-
lainen O. Asymptomatic deep venous thrombosis in the calf:
accuracy and limitations of ultrasonography as a screening test
after total knee arthroplasty. Br J Radiol 1993; 66(783):199–202.
27 Mantoni M, Strandberg C, Neergaard K, Sloth C, Jorgensen
Extended Lower Limb Venous Ultrasound for Asymptomatic DVT 443
Eur J Vasc Endovasc Surg Vol 27, April 2004
PS, Thamsen H et al. Triplex US in the diagnosis of asymptomatic
deep venous thrombosis. Acta Radiol 1997; 38(2):327–331.
28 Verlato F, Bruchi O, Prandoni P, Camporese G, Maso G,
Busonera F et al. The value of ultrasound screening for proximal
vein thrombosis after total hip arthroplasty—a prospective
cohort study. W.O.D.O.S. Investigators Group. Warfarin Optimal
Duration Orthopaedic Study. Thromb Haemost 2001; 86(2):
534–537.
29 Barrellier MT, Somon T, Speckel D, Fournier L, Denizet D.
Duplex ultrasonography in the diagnosis of deep vein thrombo-
sis of the legs. Agreement between two operators. J Mal Vasc
1992; 17(3):196–201.
30 Ascani A, Radicchia S, Parise P, Nenci GG, Agnelli G.
Distribution and occlusiveness of thrombi in patients with
surveillance detected deep vein thrombosis after hip surgery.
Thromb Haemost 1996; 75(2):239–241.
31 Barrellier MT, Bosson JL, Vignon C, Rousseau JF, Aubriot JH,
Vielpeau C. Detection of deep vein thrombosis of the limbs by
ultrasound in orthopedic and traumatologic surgery. Results of
1647 studied patients. Rev Chir Orthop Reparatrice Appar Mot 1994;
80(8):711–719.
32 Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. The
incidence of symptomatic venous thromboembolism during and
after prophylaxis with enoxaparin: a multi-institutional cohort
study of patients who underwent hip or knee arthroplasty.
Canadian Collaborative Group. Arch Intern Med 1998; 158(8):
873–878.
33 Robinson KS, Anderson DR, Gross M, Petrie D, Leighton R,
Stanish W et al. Ultrasonographic screening before hospital
discharge for deep venous thrombosis after arthroplasty: the
post-arthroplasty screening study. A randomized, controlled
trial. Ann Intern Med 1997; 127(6):439–445.
34 Sarasin FP, Bounameaux H. Antithrombotic strategy after total
hip replacement. A cost-effectiveness analysis comparing pro-
longed oral anticoagulants with screening for deep vein
thrombosis. Arch Intern Med 1996; 156(15):1661–1668.
35 Warwick D, Williams MH, Bannister GC. Death and
thromboembolic disease after total hip replacement. A series of
1162 cases with no routine chemical prophylaxis. J Bone Joint Surg
Br 1995; 77(1):6–10.
36 White RH, Romano PS, Zhou H, Rodrigo J, Bargar W.
Incidence and time course of thromboembolic outcomes follow-
ing total hip or knee arthroplasty. Arch Intern Med 1998; 158(14):
1525–1531.
37 Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative
fondaparinux versus postoperative enoxaparin for prevention of
venous thromboembolism after elective hip-replacement sur-
gery: a randomised double-blind trial. Lancet 2002; 359(9319):
1721–1726.
38 Kim YH, Kim JS. Incidence and natural history of deep-vein
thrombosis after total knee arthroplasty. A prospective, random-
ised study. J Bone Joint Surg Br 2002; 84(4):566–570.
Accepted 17 December 2003
A. Elias et al.444
Eur J Vasc Endovasc Surg Vol 27, April 2004
